Baixar PDF
Artigo anterior
Voltar à página
Artigo seguinte
If you have problems to see the content please click here
Outros usuários também visualizaram estes artigos
TREATMENT BURDEN AND PATIENT PREFERENCE IN PATIENTS WITH HEMOPHILIA A OR B WITH INHIBITORS ON CONCIZUMAB PROPHYLAXIS: RESULTS FROM THE PHASE 3 EXPLORER7 STUDY
K Hampton; P Knoebl; J Odgaard-Jensen; O Stasyshyn; JJT Zaw; JS Neergaard; B Zulfikar; GG Fabbron;
Hematol Transfus Cell Ther. 2023;45 Supl 4:S458-9
HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH HEMOPHILIA A OR B WITH INHIBITORS ON CONCIZUMAB PROPHYLAXIS: RESULTS FROM THE PHASE 3 EXPLORER7 STUDY
AD Shapiro; A Abraham; S Linari; JS Neergaard; J Odgaard-Jensen; JJT Zaw; H Tran; GG Fabbron;
Hematol Transfus Cell Ther. 2023;45 Supl 4:S458
MOTIVATORS AND BARRIERS FOR PEOPLE WITH SICKLE CELL DISEASE CONSIDERING PARTICIPATION IN CLINICAL TRIALS: FINDINGS FROM THE LISTEN SURVEY ¿ FOCUS ON BRAZIL
GG Fabbron; S Al-Behaisi; G Morrell;
Hematol Transfus Cell Ther. 2024;46 Supl 4:S66-7